scholarly journals Homocysteine Concentrations in Cord Blood of Healthy Newborn Infants

1999 ◽  
Vol 45 ◽  
pp. 767-767
Author(s):  
G Oroszlán ◽  
T Szabó
1976 ◽  
Vol 35 (03) ◽  
pp. 712-716 ◽  
Author(s):  
D. Del Principe ◽  
G Mancuso ◽  
A Menichelli ◽  
G Maretto ◽  
G Sabetta

SummaryThe authors compared the oxygen consumption in platelets from the umbilical cord blood of 36 healthy newborn infants with that of 27 adult subjects, before and after thrombin addition (1.67 U/ml). Oxygen consumption at rest was 6 mμmol/109/min in adult control platelets and 5.26 in newborn infants. The burst in oxygen consumption after thrombin addition was 26.30 mμmol/109/min in adults and 24.90 in infants. Dinitrophenol did not inhibit the burst of O2 consumption in platelets in 8 out of 10 newborn infants, while the same concentration caused a decrease in 9 out of 10 adult subjects. Deoxyglucose inhibited the burst in O2 consumption in newborn infant and adult platelets by about 50%. KCN at the concentration of 10−4 M completely inhibited basal oxygen consumption but did not completely inhibit the burst after thrombin. At the concentration of 10−3 M, it inhibited both basal O2 consumption and the burst in infants and adult subjects.


PEDIATRICS ◽  
1970 ◽  
Vol 45 (1) ◽  
pp. 155-155
Author(s):  
Judith M. Chessells ◽  
W. R. Pitney

Drs. Stiehm and Clatanoff (Pediatrics, 43: 770, 1969) report a high incidence of split products of fibrin (SPF) in the cord blood of healthy newborn infants. This is contrary to our own experience which had indicated the presence of SPF in only 5% of healthy newborns. We use a hemagglutination inhibition technique which is at least as sensitive as the tube precipitin assay employed by Drs. Stiehm and Clatanoff. The two methods differ in one important aspect, however; we have tested cord blood drawn into a mixture of sodium citrate and epsilon amino-caproic acid to inhibit in vitro fibrinolysis.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 5092-5092
Author(s):  
Mikko Eskola ◽  
Sari Juutistenaho ◽  
Kari Aranko ◽  
Susanna Sainio ◽  
Riitta Kekomäki

Abstract Abstract 5092 BACKGROUND AND OBJECTIVE Cord blood (CB), used for hematopoietic stem cell transplantation, is readily available from CB banks, and the banking processes are widely standardized. The data collected in CB banks have been utilized to characterize the contents of CB units and, to some extent, the physiological phenomena of healthy newborn infants. The objective of this study was to evaluate the association of the hemoglobin concentration (Hb), whose measurement is independent of the cell counts, with CB cell characteristics (red blood cells, RBC, hematocrit, Hct, mean platelet volume, MPV, platelets, PLT and white blood cells, WBC). The internal associations of cell counts were also evaluated. MATERIALS AND METHODS The study comprised 167 consecutive ex utero CB collections accepted for processing. All the infants (52% male) were healthy and delivered at term. Of the deliveries 104 (62%) were by Cesarean section. Perinatal data were obtained from the maternity hospital records. The relative birth weight was expressed as a birth weight z-score to normalize the birth weight for gestational age and gender. The median birth weight was 3784 g (range 2490 – 4975) and the median relative birth weight 0.49 SD (-2.41 – 3.37). The mode of delivery did not significantly influence these values. Umbilical artery (UA) pH samples were drawn after delivery as part of routine hospital care. A hematology analyzer utilizing the electronic resistance detection method coupled with volumetric (cell analysis) and colorimetric (Hb) principles was used for cell counting (Sysmex K1000, Sysmex Corp., Kobe, Japan). All the concentrations were standardized to exclude the effect of the varying blood-to-anticoagulant ratio. (Aroviita et al. Acta Paediatr 2004;93:1323-1329) CD34+ cell analysis was performed with a flow cytometer based on ISHAGE guidelines. Two-sided p values <0.05 were considered statistically significant. The CB banking program was approved by the ethical committees of the institutes. RESULTS The hematological values and their distributions were within the published ranges. (Nathan and Oski's Hematology of infancy and childhood, 7th ed. 2009) Hb (median 174 g/L, range 130 – 234) correlated with the RBC concentration (4.70 ×1012/L, 3.46 – 6.62; r = 0.96, p < 0.0001), as expected. Interestingly, MPV (8.7 fL, 7.5 – 11.5) correlated with Hb (r = 0.22, p = 0.0043), RBC concentration (r = 0.26, p = 0.0008), and Hct (53.6%, 40.1 – 73.1; r = 0.26, p = 0.0008). The PLT concentration (270 × 109/L, 161 – 607) and plateletcrit (defined as PLT concentration x MPV; 0.24%, 0.15 – 0.48) correlated negatively with Hb (r = -0.31, p < 0.0001 and r = -0.26, p = 0.0008, respectively). Hb also correlated with the WBC concentration (15.1 ×109/L, 5.54 – 39.7; r = 0.23, p = 0.0024). No correlation was observed between UA pH (7.28, 7.04 – 7.4) and the CB cell counts, except for the WBC concentration (r = -0.36, p < 0.0001) and CD34+ cell concentration (43.9 ×106/L, 7.14 - 253; r = -0.37, p < 0.0001). The CB PLT concentration and UA pH differed significantly between vaginal delivery and Cesarean section (p = 0.0053 and p = 0.0002, respectively). CONCLUSIONS Valuable information about neonatal hematology can be obtained through careful analysis of perinatal and CB banking data. Hb and the cell characteristics of CB reveal strictly controlled internal associations which seem to reflect the general activity of hematopoiesis. Disclosures No relevant conflicts of interest to declare.


1993 ◽  
Vol 123 (3) ◽  
pp. 465-467 ◽  
Author(s):  
M. Raes ◽  
P. Alliet ◽  
P. Gillis ◽  
A. Zimmermann ◽  
J. Kortleven ◽  
...  

2018 ◽  
Vol 42 (5) ◽  
pp. 171-175
Author(s):  
Alper Orhon ◽  
Hatice Topal ◽  
Nilay Hakan ◽  
Esra Arun Ozer

AbstractBackgroundThe aim of this study was to evaluate if the cord blood nucleated red blood cell (nRBC) levels can predict the development of hyperbilirubinemia in healthy neonates.MethodsAll healthy newborn infants born after 35 or more weeks of gestation at our hospital between January 2016 and April 2017 were included. The levels of nRBC were counted in umbilical cord blood samples. Neonates were grouped into two study groups based on the presence or absence of neonatal jaundice.ResultsThe study included overall 149 eligible newborn infants. The levels of nRBC and absolute nRBC count showed statistically significant differences between newborns with or without jaundice (p=0.01 and 0.02, respectively).ConclusionsWe suggest that increased nRBC counts in cord blood may be a predictive marker for hyperbilirubinemia in healthy newborn infants.


1970 ◽  
Vol 33 (2) ◽  
pp. 50-54 ◽  
Author(s):  
Zakia Nahar ◽  
Md Shahidullah ◽  
Abdul Mannan ◽  
Sanjoy Kumar Dey ◽  
Ujjal Mitra ◽  
...  

The present study was conducted to investigate the predictability of early serumbilirubin levels on the subsequent development of neonatal hyperbilirubinemia. Forthis purpose 84 healthy newborn infants were enrolled and followed up for first 5 daysof life. Study subjects were divided into two groups. Group-I consisted of 71 subjects,who did not develop significant hyperbilirubinemia (bilirubin <17mg/dl); Group-IIconsisted of 13 newborns, who developed significant hyperbilirubinemia (bilirubin >17mg/dl) during the follow up. Of the enrolled subjects, 46 (55%) were male and rest 38(45%) were female; 64 (76%) were term babies and 20 (24%) were pre-term babies.Significantly higher percentage of pre-term babies developed hyperbilirubinemia. ROC(receiver operating characteristic) analysis demonstrates that the critical value ofcord blood bilirubin >2.5mg/dl had the high sensitivity (77%) and specificity (98.6%)to predict the newborn who would develop significant hyperbilirubinemia. At this levelthe negative predictive value was 96% and positive predictive value 91%. In oursetting infants having umbilical cord blood total serum bilirubin (TSB) >2.5 mg/dlshould be followed up strictly either in hospital or as an outpatient department on day5 if practicable. Infants having TSB <2.5mg/dl in cord blood can be discharged early.Key words: Umbilical cord bilirubin; neonatal jaundice; healthy newborn.DOI: 10.3329/bjch.v33i2.5677Bangladesh Journal of Child Health 2009; Vol.33(2): 50-54


1981 ◽  
Vol 97 (2) ◽  
pp. 186-195 ◽  
Author(s):  
B.-A. Lamberg ◽  
E. Ikonen ◽  
K. Teramo ◽  
G. Wägar ◽  
K. Österlund ◽  
...  

Abstract. Eleven pregnant women with concomitant hyperthyroidism were treated with antithyroid drugs. At monthly intervals serum thyroxine (T4) and triiodothyronine (T3) were measured with radioimmunoassay, the Sephadex uptake of radioactive triiodothyronine (T3U) determined and the free T4 and T3 indices calculated (FT4I, FT3I). TSH-binding inhibiting immunoglobulins (TBII) were determined by the radiomembrane assay. Serum TSH and T4 were measured at delivery from cord blood and/or from the newborn infants some days after birth. Serum TSH was significantly elevated in one infant. There was an inadequate post-partal rise in serum T4 concentration in this child and in another who showed only a marginal elevation of TSH. The mothers of these infants were given carbimazole in doses of 30 and 25 mg/day, respectively, at the time of delivery. No significant changes were seen in other infants, the daily doses being 20 mg of carbimazole or less. There was no clinical indication of hypo- or hyperthyroidism in any of the newborn. The TBII were positive in most patients and there was a trend of normalization during treatment. No relationship between the dose of antithyroid drug and the level of TBII could be seen. During treatment the dose was adjusted according to the FT3I values. This seems to be an adequate laboratory test for this purpose.


Sign in / Sign up

Export Citation Format

Share Document